Alphatec Reports 4Q17, 2017 Revenue
Alphatec Spine posted 4Q17 revenue of US $26.3MM, -2.9% vs. 4Q16, and 2017 revenue of $101.8MM, -15.4% vs. 2016. Mar 13, 2018
Vericel Reports Orthobiologics Growth for 4Q17, 2017
Vericel posted 4Q17 orthobiologic revenue of US $16.1MM, +26.8% vs. 4Q16, and 2017 revenue of $43.9MM, +13.2% vs. 2016. Mar 13, 2018
Exactech Receives FDA Clearance for Equinoxe Stemless Shoulder
Exactech received FDA 510(k) clearance to market the Equinoxe® Stemless Shoulder for total shoulder arthroplasty. Mar 12, 2018
Kuros Biosciences Granted EU Patent for Osteoinductive Materials
Kuros Biosciences was granted a European Patent covering technology for MagnetOs osteoinductive calcium phosphates and their methods of production. Mar 12, 2018
Okani Medical Developing All-Polymer Knee Implant
Okani Medical Technology has developed ORGKnee, an all-polymer knee implant based on Zeniva® PEEK material from Solvay. Product launch is slated for 2020. Mar 09, 2018
Tyber Medical Fully Launches TyFix Extremity Joint Fixation
Tyber Medical commenced full launch of the TyFix all-in-one sterile-packed extremity joint fixation system. Mar 09, 2018
Alphatec Spine Acquires SafeOp, Provider of Neuromonitoring Tech
Alphatec Spine acquired SafeOp Surgical, provider of neuromonitoring technology, for an initial outlay of US $15MM, and also announced new leadership appointments. Mar 09, 2018
Enhatch Launching Fit2Kit Tech to Support Patient-Specific Implant Delivery
Enhatch released Fit2Kit, a patient-drivien technology platform combining elements of planning software, inventory control and sales management tools to support delivery of orthopaedic implants. Mar 09, 2018
Geisinger, Medacta Collaborate on ProvenCare Total Hip Program
Geisinger and Medacta are launching a pilot program to provide a Geisinger Health Plan member with lifetime coverage for future surgical care and costs following total hip replacement. Mar 08, 2018
ConforMIS iTotal CR Survivorship: 4-Year Data
Summarized registry data indicates that patients treated with the Conformis iTotal CR knee experienced a cumulative revision rate of 0.5% at 4 years vs. a 1.9% rate for all TKR patients. Mar 08, 2018
